nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—ACE—polycystic ovary syndrome	0.788	1	CbGaD
Perindopril—ACE—tunica intima—polycystic ovary syndrome	0.0175	0.248	CbGeAlD
Perindopril—Seasonal allergy—Metformin—polycystic ovary syndrome	0.0117	0.12	CcSEcCtD
Perindopril—Rhinitis seasonal—Metformin—polycystic ovary syndrome	0.0112	0.115	CcSEcCtD
Perindopril—ACE—urine—polycystic ovary syndrome	0.00863	0.122	CbGeAlD
Perindopril—ACE—Metabolism of Angiotensinogen to Angiotensins—CPB2—polycystic ovary syndrome	0.00613	0.169	CbGpPWpGaD
Perindopril—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00302	0.0311	CcSEcCtD
Perindopril—SLC15A1—endometrium—polycystic ovary syndrome	0.00285	0.0403	CbGeAlD
Perindopril—ACE—embryo—polycystic ovary syndrome	0.00279	0.0395	CbGeAlD
Perindopril—SLC15A1—vagina—polycystic ovary syndrome	0.00213	0.0302	CbGeAlD
Perindopril—ACE—Peptide hormone metabolism—CGB5—polycystic ovary syndrome	0.00213	0.0585	CbGpPWpGaD
Perindopril—Ear pain—Metformin—polycystic ovary syndrome	0.00208	0.0214	CcSEcCtD
Perindopril—ACE—endometrium—polycystic ovary syndrome	0.00204	0.0289	CbGeAlD
Perindopril—SLC15A1—endocrine gland—polycystic ovary syndrome	0.002	0.0282	CbGeAlD
Perindopril—Renal impairment—Metformin—polycystic ovary syndrome	0.00187	0.0192	CcSEcCtD
Perindopril—ACE—pituitary gland—polycystic ovary syndrome	0.00185	0.0261	CbGeAlD
Perindopril—ACE—adipose tissue—polycystic ovary syndrome	0.00184	0.026	CbGeAlD
Perindopril—SLC15A2—endometrium—polycystic ovary syndrome	0.00178	0.0252	CbGeAlD
Perindopril—Pain in extremity—Metformin—polycystic ovary syndrome	0.00178	0.0183	CcSEcCtD
Perindopril—Migraine—Metformin—polycystic ovary syndrome	0.00175	0.018	CcSEcCtD
Perindopril—ACE—adrenal gland—polycystic ovary syndrome	0.00165	0.0233	CbGeAlD
Perindopril—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00162	0.0167	CcSEcCtD
Perindopril—ACE—Peptide hormone metabolism—CPB2—polycystic ovary syndrome	0.00161	0.0443	CbGpPWpGaD
Perindopril—SLC15A2—pituitary gland—polycystic ovary syndrome	0.00161	0.0228	CbGeAlD
Perindopril—Breast disorder—Metformin—polycystic ovary syndrome	0.0016	0.0165	CcSEcCtD
Perindopril—Cramp muscle—Metformin—polycystic ovary syndrome	0.0016	0.0164	CcSEcCtD
Perindopril—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00159	0.0163	CcSEcCtD
Perindopril—ACE—female gonad—polycystic ovary syndrome	0.00154	0.0218	CbGeAlD
Perindopril—BCHE—endometrium—polycystic ovary syndrome	0.00151	0.0213	CbGeAlD
Perindopril—Pancreatitis—Metformin—polycystic ovary syndrome	0.0015	0.0155	CcSEcCtD
Perindopril—Angina pectoris—Metformin—polycystic ovary syndrome	0.00149	0.0154	CcSEcCtD
Perindopril—SLC15A2—adrenal gland—polycystic ovary syndrome	0.00144	0.0204	CbGeAlD
Perindopril—Neutropenia—Metformin—polycystic ovary syndrome	0.00143	0.0148	CcSEcCtD
Perindopril—ACE—endocrine gland—polycystic ovary syndrome	0.00143	0.0202	CbGeAlD
Perindopril—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00143	0.0147	CcSEcCtD
Perindopril—BCHE—uterus—polycystic ovary syndrome	0.00139	0.0197	CbGeAlD
Perindopril—Drowsiness—Metformin—polycystic ovary syndrome	0.00137	0.0141	CcSEcCtD
Perindopril—BCHE—pituitary gland—polycystic ovary syndrome	0.00137	0.0193	CbGeAlD
Perindopril—BCHE—adipose tissue—polycystic ovary syndrome	0.00136	0.0192	CbGeAlD
Perindopril—SLC15A2—female gonad—polycystic ovary syndrome	0.00134	0.019	CbGeAlD
Perindopril—SLC15A2—vagina—polycystic ovary syndrome	0.00133	0.0189	CbGeAlD
Perindopril—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00129	0.0133	CcSEcCtD
Perindopril—Spirapril—ACE—polycystic ovary syndrome	0.00128	0.163	CrCbGaD
Perindopril—Bradycardia—Metformin—polycystic ovary syndrome	0.00125	0.0129	CcSEcCtD
Perindopril—SLC15A2—endocrine gland—polycystic ovary syndrome	0.00125	0.0176	CbGeAlD
Perindopril—Rhinitis—Metformin—polycystic ovary syndrome	0.00123	0.0127	CcSEcCtD
Perindopril—Hepatitis—Metformin—polycystic ovary syndrome	0.00123	0.0126	CcSEcCtD
Perindopril—Moexipril—ACE—polycystic ovary syndrome	0.00122	0.157	CrCbGaD
Perindopril—ACE—Peptide hormone metabolism—INHBB—polycystic ovary syndrome	0.00122	0.0336	CbGpPWpGaD
Perindopril—BCHE—adrenal gland—polycystic ovary syndrome	0.00122	0.0172	CbGeAlD
Perindopril—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00121	0.0124	CcSEcCtD
Perindopril—Eye disorder—Metformin—polycystic ovary syndrome	0.00115	0.0118	CcSEcCtD
Perindopril—Flushing—Metformin—polycystic ovary syndrome	0.00114	0.0117	CcSEcCtD
Perindopril—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00114	0.0117	CcSEcCtD
Perindopril—Quinapril—ACE—polycystic ovary syndrome	0.00114	0.146	CrCbGaD
Perindopril—Cilazapril—ACE—polycystic ovary syndrome	0.00114	0.146	CrCbGaD
Perindopril—BCHE—vagina—polycystic ovary syndrome	0.00113	0.016	CbGeAlD
Perindopril—Angiopathy—Metformin—polycystic ovary syndrome	0.00111	0.0115	CcSEcCtD
Perindopril—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00111	0.0114	CcSEcCtD
Perindopril—Ramipril—ACE—polycystic ovary syndrome	0.0011	0.141	CrCbGaD
Perindopril—Trandolapril—ACE—polycystic ovary syndrome	0.0011	0.141	CrCbGaD
Perindopril—Chills—Metformin—polycystic ovary syndrome	0.0011	0.0113	CcSEcCtD
Perindopril—Erythema—Metformin—polycystic ovary syndrome	0.00107	0.011	CcSEcCtD
Perindopril—Malnutrition—Metformin—polycystic ovary syndrome	0.00107	0.011	CcSEcCtD
Perindopril—BCHE—endocrine gland—polycystic ovary syndrome	0.00106	0.015	CbGeAlD
Perindopril—Flatulence—Metformin—polycystic ovary syndrome	0.00105	0.0108	CcSEcCtD
Perindopril—Dysgeusia—Metformin—polycystic ovary syndrome	0.00105	0.0108	CcSEcCtD
Perindopril—Muscle spasms—Metformin—polycystic ovary syndrome	0.00103	0.0106	CcSEcCtD
Perindopril—Tremor—Metformin—polycystic ovary syndrome	0.001	0.0103	CcSEcCtD
Perindopril—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000992	0.0102	CcSEcCtD
Perindopril—ABCB1—embryo—polycystic ovary syndrome	0.000983	0.0139	CbGeAlD
Perindopril—Malaise—Metformin—polycystic ovary syndrome	0.000964	0.00992	CcSEcCtD
Perindopril—Syncope—Metformin—polycystic ovary syndrome	0.000959	0.00986	CcSEcCtD
Perindopril—Palpitations—Metformin—polycystic ovary syndrome	0.000945	0.00972	CcSEcCtD
Perindopril—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00094	0.00967	CcSEcCtD
Perindopril—ABCB1—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.000929	0.0255	CbGpPWpGaD
Perindopril—Hypertension—Metformin—polycystic ovary syndrome	0.000923	0.00949	CcSEcCtD
Perindopril—Myalgia—Metformin—polycystic ovary syndrome	0.00091	0.00936	CcSEcCtD
Perindopril—Chest pain—Metformin—polycystic ovary syndrome	0.00091	0.00936	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000904	0.0093	CcSEcCtD
Perindopril—ACE—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.000904	0.0248	CbGpPWpGaD
Perindopril—Discomfort—Metformin—polycystic ovary syndrome	0.000899	0.00925	CcSEcCtD
Perindopril—Oedema—Metformin—polycystic ovary syndrome	0.000872	0.00898	CcSEcCtD
Perindopril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—polycystic ovary syndrome	0.000868	0.0239	CbGpPWpGaD
Perindopril—Shock—Metformin—polycystic ovary syndrome	0.000858	0.00883	CcSEcCtD
Perindopril—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000856	0.0088	CcSEcCtD
Perindopril—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000854	0.00879	CcSEcCtD
Perindopril—BCHE—Peptide hormone metabolism—CGB5—polycystic ovary syndrome	0.000854	0.0235	CbGpPWpGaD
Perindopril—Skin disorder—Metformin—polycystic ovary syndrome	0.000847	0.00872	CcSEcCtD
Perindopril—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000843	0.00868	CcSEcCtD
Perindopril—Enalapril—ACE—polycystic ovary syndrome	0.000836	0.107	CrCbGaD
Perindopril—Anorexia—Metformin—polycystic ovary syndrome	0.000832	0.00856	CcSEcCtD
Perindopril—Hypotension—Metformin—polycystic ovary syndrome	0.000815	0.00839	CcSEcCtD
Perindopril—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000805	0.0114	CbGeAlD
Perindopril—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000795	0.00818	CcSEcCtD
Perindopril—Paraesthesia—Metformin—polycystic ovary syndrome	0.000783	0.00806	CcSEcCtD
Perindopril—Dyspnoea—Metformin—polycystic ovary syndrome	0.000778	0.008	CcSEcCtD
Perindopril—Somnolence—Metformin—polycystic ovary syndrome	0.000776	0.00798	CcSEcCtD
Perindopril—Dyspepsia—Metformin—polycystic ovary syndrome	0.000768	0.0079	CcSEcCtD
Perindopril—BCHE—Glycerophospholipid biosynthesis—LPCAT2—polycystic ovary syndrome	0.000759	0.0209	CbGpPWpGaD
Perindopril—Decreased appetite—Metformin—polycystic ovary syndrome	0.000758	0.0078	CcSEcCtD
Perindopril—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000753	0.00775	CcSEcCtD
Perindopril—Fatigue—Metformin—polycystic ovary syndrome	0.000752	0.00774	CcSEcCtD
Perindopril—Constipation—Metformin—polycystic ovary syndrome	0.000746	0.00768	CcSEcCtD
Perindopril—ABCB1—endometrium—polycystic ovary syndrome	0.000719	0.0102	CbGeAlD
Perindopril—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000719	0.0074	CcSEcCtD
Perindopril—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000713	0.00734	CcSEcCtD
Perindopril—Urticaria—Metformin—polycystic ovary syndrome	0.000693	0.00713	CcSEcCtD
Perindopril—Abdominal pain—Metformin—polycystic ovary syndrome	0.00069	0.0071	CcSEcCtD
Perindopril—ABCB1—uterus—polycystic ovary syndrome	0.000663	0.00937	CbGeAlD
Perindopril—ABCB1—pituitary gland—polycystic ovary syndrome	0.000651	0.0092	CbGeAlD
Perindopril—ABCB1—adipose tissue—polycystic ovary syndrome	0.000648	0.00916	CbGeAlD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—polycystic ovary syndrome	0.000647	0.0178	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—CPB2—polycystic ovary syndrome	0.000647	0.0178	CbGpPWpGaD
Perindopril—Asthenia—Metformin—polycystic ovary syndrome	0.000626	0.00644	CcSEcCtD
Perindopril—Pruritus—Metformin—polycystic ovary syndrome	0.000617	0.00635	CcSEcCtD
Perindopril—Diarrhoea—Metformin—polycystic ovary syndrome	0.000597	0.00614	CcSEcCtD
Perindopril—ACE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.000597	0.0164	CbGpPWpGaD
Perindopril—ABCB1—adrenal gland—polycystic ovary syndrome	0.000581	0.00822	CbGeAlD
Perindopril—Dizziness—Metformin—polycystic ovary syndrome	0.000577	0.00594	CcSEcCtD
Perindopril—ABCB1—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000559	0.0154	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.000555	0.0153	CbGpPWpGaD
Perindopril—Vomiting—Metformin—polycystic ovary syndrome	0.000555	0.00571	CcSEcCtD
Perindopril—Rash—Metformin—polycystic ovary syndrome	0.00055	0.00566	CcSEcCtD
Perindopril—Dermatitis—Metformin—polycystic ovary syndrome	0.00055	0.00565	CcSEcCtD
Perindopril—Headache—Metformin—polycystic ovary syndrome	0.000547	0.00562	CcSEcCtD
Perindopril—ABCB1—female gonad—polycystic ovary syndrome	0.000542	0.00766	CbGeAlD
Perindopril—ABCB1—vagina—polycystic ovary syndrome	0.000539	0.00761	CbGeAlD
Perindopril—BCHE—Phospholipid metabolism—LPCAT2—polycystic ovary syndrome	0.00053	0.0146	CbGpPWpGaD
Perindopril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—polycystic ovary syndrome	0.000522	0.0144	CbGpPWpGaD
Perindopril—Nausea—Metformin—polycystic ovary syndrome	0.000518	0.00533	CcSEcCtD
Perindopril—ABCB1—endocrine gland—polycystic ovary syndrome	0.000504	0.00713	CbGeAlD
Perindopril—BCHE—Glycerophospholipid biosynthesis—PNPLA2—polycystic ovary syndrome	0.000503	0.0138	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—INHBB—polycystic ovary syndrome	0.00049	0.0135	CbGpPWpGaD
Perindopril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—INS—polycystic ovary syndrome	0.000446	0.0123	CbGpPWpGaD
Perindopril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—polycystic ovary syndrome	0.000431	0.0119	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.000402	0.011	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.000367	0.0101	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—LHB—polycystic ovary syndrome	0.000363	0.00997	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.000359	0.00987	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PNPLA2—polycystic ovary syndrome	0.000351	0.00965	CbGpPWpGaD
Perindopril—ABCB1—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000337	0.00926	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000309	0.00851	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.000308	0.00848	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.000307	0.00843	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.000304	0.00837	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.000304	0.00837	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.000297	0.00816	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000287	0.0079	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.000239	0.00658	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—ACE—polycystic ovary syndrome	0.000232	0.00638	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.000231	0.00634	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.000223	0.00613	CbGpPWpGaD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB1—polycystic ovary syndrome	0.000221	0.00606	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00022	0.00606	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000207	0.00569	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000205	0.00563	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000199	0.00548	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—polycystic ovary syndrome	0.000194	0.00533	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000185	0.00509	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000171	0.00469	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000171	0.00469	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—FOXP3—polycystic ovary syndrome	0.000169	0.00465	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.000161	0.00443	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—TFRC—polycystic ovary syndrome	0.000154	0.00423	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000153	0.00419	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.000147	0.00405	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.000144	0.00396	CbGpPWpGaD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000139	0.00383	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000135	0.00371	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000135	0.00371	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000133	0.00367	CbGpPWpGaD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000129	0.00355	CbGpPWpGaD
Perindopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000127	0.0035	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000126	0.00347	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.000124	0.0034	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.000123	0.00338	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.000122	0.00336	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.000122	0.00336	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.000119	0.00327	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000118	0.00324	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000113	0.00311	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000113	0.0031	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000107	0.00295	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000105	0.00288	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000102	0.00281	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000102	0.00281	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	9.71e-05	0.00267	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	9.49e-05	0.00261	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	9.26e-05	0.00255	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—DLG4—polycystic ovary syndrome	9.03e-05	0.00248	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	8.69e-05	0.00239	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	8.6e-05	0.00237	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	8.32e-05	0.00229	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NMNAT3—polycystic ovary syndrome	8.31e-05	0.00228	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	8.3e-05	0.00228	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	7.92e-05	0.00218	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	7.75e-05	0.00213	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.74e-05	0.00213	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	7.72e-05	0.00212	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SUOX—polycystic ovary syndrome	7.6e-05	0.00209	CbGpPWpGaD
Perindopril—BCHE—Metabolism—LPCAT2—polycystic ovary syndrome	7.6e-05	0.00209	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	7.5e-05	0.00206	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.18e-05	0.00197	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	7.07e-05	0.00195	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ISYNA1—polycystic ovary syndrome	7.06e-05	0.00194	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	6.92e-05	0.0019	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	6.9e-05	0.0019	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—LHB—polycystic ovary syndrome	6.85e-05	0.00188	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—LEP—polycystic ovary syndrome	6.78e-05	0.00186	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	6.75e-05	0.00186	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	6.58e-05	0.00181	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	6.57e-05	0.00181	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	6.44e-05	0.00177	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	6.26e-05	0.00172	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	6.12e-05	0.00168	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	6.11e-05	0.00168	CbGpPWpGaD
Perindopril—BCHE—Metabolism—AKR1C2—polycystic ovary syndrome	6.01e-05	0.00165	CbGpPWpGaD
Perindopril—BCHE—Metabolism—TEAD2—polycystic ovary syndrome	6.01e-05	0.00165	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.94e-05	0.00163	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—POMC—polycystic ovary syndrome	5.82e-05	0.0016	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—INS—polycystic ovary syndrome	5.79e-05	0.00159	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	5.77e-05	0.00159	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	5.68e-05	0.00156	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—IGF1—polycystic ovary syndrome	5.6e-05	0.00154	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.51e-05	0.00152	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	5.11e-05	0.00141	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	5.07e-05	0.00139	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PNPLA2—polycystic ovary syndrome	5.03e-05	0.00138	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SRD5A1—polycystic ovary syndrome	4.77e-05	0.00131	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	4.64e-05	0.00128	CbGpPWpGaD
Perindopril—BCHE—Metabolism—STAR—polycystic ovary syndrome	4.55e-05	0.00125	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	4.52e-05	0.00124	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.5e-05	0.00124	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—ACE—polycystic ovary syndrome	4.38e-05	0.0012	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	4.36e-05	0.0012	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	4.21e-05	0.00116	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HMMR—polycystic ovary syndrome	4.06e-05	0.00112	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	4.05e-05	0.00111	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	4.02e-05	0.00111	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	3.87e-05	0.00106	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.83e-05	0.00105	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	3.71e-05	0.00102	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	3.71e-05	0.00102	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.63e-05	0.000997	CbGpPWpGaD
Perindopril—BCHE—Metabolism—LHB—polycystic ovary syndrome	3.53e-05	0.00097	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	3.45e-05	0.000948	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	3.45e-05	0.000948	CbGpPWpGaD
Perindopril—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	3.34e-05	0.000919	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	3.07e-05	0.000845	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	3.04e-05	0.000836	CbGpPWpGaD
Perindopril—BCHE—Metabolism—RRM2—polycystic ovary syndrome	2.98e-05	0.000819	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	2.93e-05	0.000806	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	2.93e-05	0.000806	CbGpPWpGaD
Perindopril—BCHE—Metabolism—YAP1—polycystic ovary syndrome	2.87e-05	0.000789	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	2.76e-05	0.000758	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.74e-05	0.000754	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	2.72e-05	0.000749	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	2.72e-05	0.000748	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.7e-05	0.000743	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.65e-05	0.000729	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.61e-05	0.000718	CbGpPWpGaD
Perindopril—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	2.57e-05	0.000707	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	2.53e-05	0.000696	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	2.46e-05	0.000675	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.43e-05	0.000667	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	2.34e-05	0.000642	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	2.33e-05	0.00064	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	2.32e-05	0.000639	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	2.25e-05	0.000618	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—STAR—polycystic ovary syndrome	2.22e-05	0.000611	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.22e-05	0.00061	CbGpPWpGaD
Perindopril—BCHE—Metabolism—TH—polycystic ovary syndrome	2.19e-05	0.000602	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	2.13e-05	0.000586	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	2e-05	0.000551	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.98e-05	0.000546	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.98e-05	0.000544	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.89e-05	0.000519	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.86e-05	0.000512	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GNAS—polycystic ovary syndrome	1.79e-05	0.000492	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.72e-05	0.000473	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	1.7e-05	0.000468	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.68e-05	0.000463	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.63e-05	0.000448	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	1.61e-05	0.000444	CbGpPWpGaD
Perindopril—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	1.51e-05	0.000414	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.5e-05	0.000412	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.45e-05	0.000399	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.4e-05	0.000385	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.35e-05	0.00037	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.33e-05	0.000365	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.25e-05	0.000345	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.24e-05	0.00034	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PPARG—polycystic ovary syndrome	1.22e-05	0.000336	CbGpPWpGaD
Perindopril—BCHE—Metabolism—POMC—polycystic ovary syndrome	1.2e-05	0.000331	CbGpPWpGaD
Perindopril—BCHE—Metabolism—INS—polycystic ovary syndrome	1.2e-05	0.000329	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.07e-05	0.000294	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.04e-05	0.000286	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	9.78e-06	0.000269	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	8.73e-06	0.00024	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	8.31e-06	0.000229	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	7.88e-06	0.000217	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	7.35e-06	0.000202	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	5.96e-06	0.000164	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—POMC—polycystic ovary syndrome	5.87e-06	0.000162	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—INS—polycystic ovary syndrome	5.84e-06	0.000161	CbGpPWpGaD
